期刊文献+

104株嗜麦芽窄食单胞菌的耐药率及其治疗方案分析 被引量:6

Analysis of Antibiotic Resistance Rates and Therapeutic Regimen of 104 Strains of Stenotrophomonas Maltophilia
下载PDF
导出
摘要 目的:分析嗜麦芽窄食单胞菌的耐药率及有效的治疗方案。方法:采用WHONET软件对医院2013年—2014年间微生室分离的嗜麦芽窄食单胞菌对抗菌药物的耐药率作了统计,并对其感染病例治疗的有效率作了回顾性分析。结果:2013年—2014年间分离的嗜麦芽窄食单胞菌104株,其中定植菌为26株,致病菌为78株;嗜麦芽窄食单胞菌感染患者78例,其年龄≥60岁占80.76%;并且57.69%患者伴有慢性呼吸道疾病;嗜麦芽窄食单胞菌对左氧氟沙星、复方磺胺甲噁唑和米诺环素的敏感率分别为82.22%、94.74%和100.00%,其对头孢哌酮-舒巴坦的耐药率为36.84%;采用的4种治疗方案分别为β-内酰胺酶抑制剂复合制剂、第3代或第4代头孢菌素、第3代头孢菌素与左氧氟沙星联用、β-内酰胺酶抑制剂复合制剂与阿米卡星联用;治疗的总有效率分别为56.60%、60.00%、58.82%和100.00%。结论:哌拉西林-他唑巴坦、头孢哌酮-舒巴坦单独或哌拉西林-他唑巴坦与阿米卡星联用,可有效治疗嗜麦芽窄食单胞菌导致的感染。 Objective: To analyze the antibiotic resistance rates and therapeutic regimen of 104 strains of Stenotro- phomonas Maltophilia(S.maltophilia). Methods: The antibiotic resistance of S.maltophilia that was isolated from our hospital during 2013-2014 was analyzed by WHONET software; treatment outcomes for S.maltophilia bacteraernia were evaluated by retrospectively analysis. Results: Total 104 strains of S.maltophilia were isolated from year 2013 to 2014, they were divided into two groups: 26 strains were colonized only and 78 strains were infected by S.maltophilia. 80.76% of patients who were infected S.maltophilia', aged ≥60, and 57.69% of infected patients has chronic respiratory disease. About 82.22%, 94.74%, 100.00% and 36.84% of the S.maltophilia isolates had sensitivity rates to levofloxacin, trimethoprim-sulfamethoxazol, minocycline and cefoperazone-sulbactam respectively. The patients who were infected 5'. maltophilia received four treatment strategies: B-lactam-enzyme inhibitor. They received the third or the fourth genera- tion cephalosporin, the third or the fourth generation cephalosporin combination with levofloxacin and B-lactaln-en- zyme inhibitor combination with amikacin; the clinical effective rate was 56.60%, 60.00%, 58.82% and 100.00%, re- spectively. Conclusion: Piperacillin-tazobactam and cefperazone-sulbactam monotherapies or piperacillin-tazobactam combinantion with amikacin were effective for the treatment orS. maltophilia infections.
出处 《抗感染药学》 2015年第3期371-374,共4页 Anti-infection Pharmacy
基金 佛山市卫生局医学科研基金项目(编号:2014238)
关键词 嗜麦芽窄食单胞菌 定植菌 致病菌 耐药率 治疗方案 Stenotrophomonas maltophilia colonized bacteria pathogenic bacteria resistance rates therapeutic regimen
  • 相关文献

参考文献6

  • 1艾效曼,胡云建,俞云松,杨青,倪语星,孙景勇,徐英春,张小江,孙自镛,陈中举,汪复,朱德妹,胡付品,卓超,苏丹虹,徐元宏,沈继录,单斌,杜艳,魏莲花,吴玲,张朝霞,季萍,王传清,王爱敏,贾蓓,黄文祥,张泓,孔菁.2011年中国CHINET嗜麦芽窄食单胞菌耐药性监测[J].中国感染与化疗杂志,2014,14(2):94-99. 被引量:20
  • 2<抗菌药物临床试验技术指导原则>写作组.抗菌药物临床试验技术指导原则[J].中国临床药理学杂志,2014,30(9):844-856. 被引量:323
  • 3Brooke JS.Stenotrophomonas maltophilia:an emerging global opportunistic pathogen[J].Clin Microb Rev,2012,25(1):2-41.
  • 4周华,李光辉,卓超,杨毅,石岩,黄晓军,吕晓菊,刘又宁,倪语星,张晓辉,周建英,俞云松,陈佰义,陈良安,何礼贤,胡必杰,邱海波,施毅,王明贵,谢灿茂.中国嗜麦芽窄食单胞菌感染诊治和防控专家共识[J].中华医学杂志,2013,93(16):1203-1213. 被引量:110
  • 5Wang YL, Scipione MR,Dubrovskaya Y,et al.Monotherapy with fluoroquinolone or trimethoprim- sulfamethoxazole for treatment of Stenotrophomonas maltophilia infec-tions[J].Antimicrob Agents and Chemotherapy,2013,58(1):176-182.
  • 6Juhasz E,Krizsan G,Lengyel G,et al Infection and colonization by Stenotrophomonas maltophilia:antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary[J].Annals of Clinical Microbiology and Antimicrobials,2014,13(1):15-23.

二级参考文献21

  • 1潘计调,陈剑平,郭来洲.嗜麦芽窄食假单孢菌致肺炎伴急性骨髓炎1例[J].中国实用医药,2007,2(14). 被引量:1
  • 2汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:284
  • 3Liu YM, Chen YS, Toh HS, et al.In vitro susceptibilities of non Enterobacteriaceae isolates from patients with intra.-ab dominal infections in the Asia-Pacific region from 2003 to 2010: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)[J]. Int J Antimicrob Agents, 2012, 40 Suppl:s11- s17.
  • 4Brooke JS. Stenotrophornonas maltophilia: an emerging global opportunistic palhogen [J ]. Clin Microbiol Rev, 2012, 25 (1): 2 -41.
  • 5Clinical and Laboratory Standards Institute (CI.SI)/ NCCI.S. Performance Standards for Antimicrobial Susceptibility tes ring Standards: twentyth Informational Supplement [S]. 2011, M100 -S21.
  • 6Abbott U, Slavin MA, Turnidge JD, et al. Stenotrophomonas ma ltophilia : emerging disease patterns and challenges for treat ment. Expert Rev[J]. Anti Infect Ther, 2011, 9(4): 471 -488.
  • 7(;hung HS, Hong SG, Kim YR, et al. Antimicrobial suscep tibility of Stenotrophomonas maltophilia isolates from Korea and the activity of antimicrobial combinations against the iso lates[J]. J Korean Med Sci,2013,28(1):62- 66.
  • 8Farrell DJ, Sader HS, Jones RN. Antimicrobial susceptibili- ties of a worldwide collection of Stenotrophomonas maltophil ia isolates tested against tigecyline and agents commonly used for S. maltophilia infections[J]. Antimicrob Agents Che mother, 2010, 54(6):2735 -2737.
  • 9汪复.2006年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2008,8(1):1-9. 被引量:281
  • 10汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,孙宏莉,胡云健,艾效曼,俞云松,杨青,孙自镛,简翠,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华.2007年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2008,8(5):325-333. 被引量:305

共引文献443

同被引文献56

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部